[TARS] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[TARS] Tarsus Pharmaceuticals, Inc.
Announcement Date
08-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 14.73%
YoY- -63.26%
Quarter Report
TARS's Result
TARS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/18 CAGR
Revenue 27,614 2,500 539 33,432 0 0 -
PBT -35,731 -23,419 -20,237 10,689 -1,957 -330 118.16%
Tax -270 -1,533 1 313 0 0 -
NP -35,731 -21,886 -20,238 10,376 -1,957 -330 118.16%
Tax Rate - - - -2.93% - - -
Total Cost 63,345 24,386 20,777 23,056 1,957 330 139.98%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/18 CAGR
NP Margin -129.39 -875.44 -3,754.73 31.04 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/18 CAGR
EPS -1.01 -0.82 -0.98 0.51 -0.18 -0.08 52.53%
EPS Diluted -1.01 -0.82 -0.98 0.47 -0.18 -0.08 52.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.